![](/img/cover-not-exists.png)
Cost analysis of bivalirudin versus reference anticoagulants without GP IIb/IIIa inhibitors in patients undergoing percutaneous coronary intervention for acute coronary syndrome in routine clinical practice. Pompidou registry
Puymirat, E., Cohen, S., Védrenne, G., Caruba, T., Sabatier, B., Danchin, N., Durand, E.Volume:
62
Journal:
Annales de Cardiologie et d'Angéiologie
DOI:
10.1016/j.ancard.2012.10.002
Date:
April, 2013
File:
PDF, 287 KB
2013